GeneCentric Therapeutics logo

GeneCentric Therapeutics Headquarters & Office Locations

Verified data Biotechnology 36 employees 5 locations worldwide

Headquarters: 100 Capitola Drive suite 275, Durham, North Carolina 27713, United States

Data last updated · Sourced via GraphIQ

Headquarters
Durham, NC
United States
Total locations
5
recorded by GraphIQ
Employees
36
est. 2026

GeneCentric Therapeutics headquarters details

Street address
100 Capitola Drive suite 275
City
Durham
State / region
North Carolina
ZIP / postal code
27713
Country
United States
Founded
2011

All GeneCentric Therapeutics office locations

5 total
CityState / regionCountryType
Durham HQNorth CarolinaUnited StatesHeadquarters

Showing the headquarters of 5 recorded locations. See every location in GraphIQ →

About GeneCentric Therapeutics

GeneCentric Therapeutics is headquartered in Durham, North Carolina, United States. Founded in 2011, the company has 5 recorded locations and employs approximately 36 people worldwide.

Where is GeneCentric Therapeutics's main office?

GeneCentric Therapeutics's main headquarters office is located at 100 Capitola Drive suite 275, Durham, North Carolina 27713, United States. This is the company's primary corporate address.

GeneCentric Therapeutics contact information

The main switchboard for GeneCentric Therapeutics headquarters can be reached at +1 919 973 6544. Official website: genecentric.com.

What does GeneCentric Therapeutics do?

GeneCentric Therapeutics engages in developing and commercializing molecular diagnostic tests for oncologists and patients. The company currently has two unique platform technologies including The Lung Subtype Platform (LSP) stratifies lung cancer patients into subtypes, which are important for appropriate therapeutic selection. The first application of LSP was licensed to and independently developed by Laboratory Corporation of America Holdings (“LabCorp”) and is now available through its specialty testing business, Integrated Oncology, as HistoPlusSM: Lung Cancer. Its second platform technology is the Hypoxia Signature which has the potential to identify patients that respond to anti-angiogenesis therapies. GeneCentric utilizes a unique partnership model to translate important cancer discoveries into clinically adopted diagnostics for pathologists, clinicians, and, most importantly, patients. The company was incorporated in 2011 and is based in Durham, North Carolina.

Frequently asked questions

Where is GeneCentric Therapeutics headquarters?

GeneCentric Therapeutics's headquarters is located at 100 Capitola Drive suite 275, Durham, North Carolina 27713, United States.

How many offices does GeneCentric Therapeutics have?

GraphIQ records 5 locations for GeneCentric Therapeutics, as of October 2026.

What is GeneCentric Therapeutics's corporate address?

The corporate headquarters address is 100 Capitola Drive suite 275, Durham, North Carolina 27713, United States.

When was GeneCentric Therapeutics founded?

GeneCentric Therapeutics was founded in 2011 and employs approximately 36 people.

What is GeneCentric Therapeutics's phone number?

The main phone number for GeneCentric Therapeutics headquarters is +1 919 973 6544.

How many employees does GeneCentric Therapeutics have?

GeneCentric Therapeutics has approximately 36 employees (GraphIQ estimate, 2026).

Find more info on GeneCentric Therapeutics using GraphIQ

Revenue teams waste hours stitching together data from a dozen tools before a single rep can make a meaningful touch. GraphIQ fixes that. Whether you're building target account lists, routing inbound leads, or keeping your CRM clean as GeneCentric Therapeutics's structure evolves, GraphIQ gives you verified company, people and location data in one place.

From territory planning and lead scoring to handoff workflows and pipeline hygiene, our platform connects the data your GTM engine needs to run without friction. Sign up today and see how GraphIQ helps your revenue team spend less time finding information and more time acting on it.

300M+Companies tracked
370M+Employees
2TNews articles & events